Bracco Imaging is a global leader in diagnostic imaging, specializing in the development, production, and commercialization of contrast agents and advanced medical technologies. The company provides innovative solutions to enhance the precision of biomedical imaging, supporting better diagnosis and management of diseases. Through its subsidiaries, including Blue Earth Diagnostics and Blue Earth Therapeutics, Bracco Imaging offers cutting-edge oncology imaging and therapeutic radiopharmaceuticals. The group also operates the Centro Diagnostico Italiano (CDI) in Milan, providing high-quality healthcare services such as prevention, diagnosis, rehabilitation, and radiosurgery, leveraging the latest technological advancements.